More Articles

audioplethysmography Google headphones
| Remote Monitoring

Researchers from Google have introduced a new approach for cardiac monitoring that relies on the active noise canceling (ANC) technology found in headphones and earbuds.

The technique,…

money business cash flow dollar
| Mergers & Acquisitions

Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The…

Medtronic extravascular ICD Aurora EV-ICD MRI SureScan
| Heart Rhythm

Medtronic has gained U.S. Food and Drug Administration (FDA) approval for a new first-of-its-kind extravascular implantable cardioverter-defibrillator (ICD) and defibrillation lead that allows…

SentiAR CommandEP system
| Cardiac Imaging

Augmented reality is becoming more common in healthcare settings, with St. Louis-based developer

Specialists at Cleveland Clinic treated a hypertrophic cardiomyopathy patient with a new gene therapy from Tenaya Therapeutics
| Heart Rhythm

Specialists at Cleveland Clinic have treated a hypertrophic cardiomyopathy (HCM) patient with a new gene therapy designed to reverse disease progression.

| TAVR

Nearly one-fifth of patients die within two years of undergoing transcatheter aortic valve replacement (TAVR), according to a new analysis…

Thumbnail
| Electrophysiology

Cardiologists are often not too concerned when atrial arrhythmias occur during the 90-day “blanking period” after catheter ablation. According to a new analysis published in JACC: Clinical Electrophysiology, however, such…

Thumbnail
| TAVR

Cardiologists can safely perform routine electrophysiology (EP) studies during…

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
| Heart Rhythm

Attune Medical, the Chicago-based healthcare technology company, has received a De Novo

Thumbnail
| TAVR

Non-vitamin K oral anticoagulants (NOACs) are associated with fewer major bleeding events and deaths than vitamin K antagonists (VKAs) when treating patients who develop new-onset atrial fibrillation (AFib) after…

Thumbnail
| Economics

Pharmacy-provided low-cost generic programs (LCGPs) can help improve patient access to affordable cardiovascular disease (CVD) medications. According to a new analysis published in Annals of Internal Medicine, however,…

cardiologist preparing to perform radiofrequency ablation
| Electrophysiology

Catheter ablation procedures may help improve the mental health of patients presenting with symptomatic atrial fibrillation (AFib), according to a new analysis published in JAMA.[1] The study’s authors identified key…

Matthew Latacha, MD, Methodist Health System, cardiologist
| Interventional Cardiology

A bicyclist killed outside Omaha, Nebraska, on the morning of Sept. 10 has been identified as Matthew Latacha, MD, a veteran cardiologist with Methodist Health System. He was 47 years old.

| Policy & Regulations

Certain intra-aortic balloon pumps (IABPs) manufactured by Datascope, a subsidiary of Getinge, have been involved in…

Thumbnail
| Electrophysiology

Pulsed field ablation (PFA) is as effective for the treatment of paroxysmal atrial fibrillation (AFib) as radiofrequency or cryoballoon ablation, according to new research presented at…

Withings Body Scan Connected Health Station FDA cleared
| Heart Health

Withings, the healthcare technology company known for its remote monitoring devices, announced that the U.S. Food and Drug Administration (FDA) has cleared its newest smart scale, the Body Scan…